bioAffinity Technologies, Inc. Increase (Decrease) in Inventories
bioAffinity Technologies, Inc. (BIAF) reported Increase (Decrease) in Inventories of $28.83 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-07
- bioAffinity Technologies, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $4.49K, a 13.45% decline year-over-year.
- bioAffinity Technologies, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $24.34K, a 117.82% increase year-over-year.
- bioAffinity Technologies, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $18.31K, a 715.77% increase year-over-year.
- bioAffinity Technologies, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$8.74K.
- bioAffinity Technologies, Inc. increase (decrease) in inventories for fiscal 2025 was $25.94K, a 184.31% increase from fiscal 2024.
- bioAffinity Technologies, Inc. increase (decrease) in inventories for fiscal 2024 was $9.12K, a 29.51% decline from fiscal 2023.
- bioAffinity Technologies, Inc. increase (decrease) in inventories for fiscal 2023 was $12.94K, a 133.65% increase from fiscal 2022.
- bioAffinity Technologies, Inc. increase (decrease) in inventories for fiscal 2022 was $5.54K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $28.83K 10-Q · filed 2026-08-07 | $47.14K derived: sum of 3 quarters · filed 2026-08-07 | $38.41K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $24.34K 10-Q · filed 2026-05-11 | $42.65K derived: sum of 2 quarters · filed 2026-05-11 | $33.92K derived: sum of 3 quarters · filed 2026-05-11 | $39.10K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $18.31K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $9.58K derived: sum of 2 quarters · filed 2026-03-16 | $14.77K derived: sum of 3 quarters · filed 2026-08-07 | $25.94K 10-K · filed 2026-03-16 |
| 2025-09-30 | -$8.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$3.55K derived: sum of 2 quarters · filed 2026-08-07 | $7.63K 10-Q · filed 2025-11-14 | $9.87K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $5.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $16.36K 10-Q · filed 2026-08-07 | $18.61K derived: sum of 3 quarters · filed 2026-08-07 | $14.20K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $11.17K 10-Q · filed 2026-05-11 | $13.42K derived: sum of 2 quarters · filed 2026-05-11 | $9.01K derived: sum of 3 quarters · filed 2026-05-11 | $29.30K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $2.25K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$2.16K derived: sum of 2 quarters · filed 2026-03-16 | $18.12K derived: sum of 3 quarters · filed 2026-03-16 | $9.12K 10-K · filed 2026-03-16 |
| 2024-09-30 | -$4.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $15.88K derived: sum of 2 quarters · filed 2025-11-14 | $6.88K 10-Q · filed 2025-11-14 | $15.46K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $20.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $11.28K 10-Q · filed 2025-08-14 | $19.86K derived: sum of 3 quarters · filed 2025-08-14 | $19.67K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$9.00K 10-Q · filed 2025-05-15 | -$421.00 derived: sum of 2 quarters · filed 2025-05-15 | -$614.00 derived: sum of 3 quarters · filed 2025-05-15 | -$1.85K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $8.58K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $8.38K derived: sum of 2 quarters · filed 2025-03-31 | $7.15K derived: sum of 3 quarters · filed 2025-03-31 | $12.94K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$193.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.43K derived: sum of 2 quarters · filed 2024-11-14 | $4.37K 10-Q · filed 2024-11-14 | $4.19K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$1.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $4.56K 10-Q · filed 2024-08-14 | $4.39K derived: sum of 3 quarters · filed 2024-08-14 | $4.44K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $5.79K 10-Q · filed 2024-05-15 | $5.62K derived: sum of 2 quarters · filed 2024-05-15 | $5.68K derived: sum of 3 quarters · filed 2024-05-15 | $5.53K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$175.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$117.00 derived: sum of 2 quarters · filed 2024-04-01 | -$263.00 derived: sum of 3 quarters · filed 2024-04-01 | $5.54K 10-K · filed 2024-04-01 |
| 2022-09-30 | $58.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$88.00 derived: sum of 2 quarters · filed 2023-11-14 | $5.71K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$146.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $5.66K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $5.80K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |